An overview of the t:slim X2 and Mobi insulin pumps with Control-IQ technology: patient safety and device efficacy.

INTRODUCTION

Type 1 diabetes is a chronic disease requiring lifelong intensive insulin treatment. Automated insulin delivery (AID) systems such as Tandem Control-IQ allow for automatic adjustment of insulin delivery and can help improve glycemic outcomes.

AREAS COVERED: This review will cover Tandem Control IQ AID technology and the Tandem t:slim X2 and Tandem Mobi insulin pumps including their physical features and function, the algorithm guiding insulin delivery, research regarding their safety and efficacy, and a brief overview of other AID systems. References were identified using PubMed.

EXPERT OPINION: AID is now being considered as the standard for management of type 1 diabetes. Tandem Control IQ technology is one of several systems currently available that allows the user to benefit from the latest diabetes technology. Optimizing use of this system can lead to improved glycemic outcomes and decreased burden of disease for people with diabetes compared to multiple daily injections or open-loop insulin pump therapy.